Afatinib dimaleate
Afatinib maleate is an orally bioavailable dual receptor tyrosine kinase (RTK) inhibitor with potential antitumor activity. EGFR/HER2 tyrosine kinase inhibitor BIBW 2992 irreversibly binds and inhibits EGFR-1 and HER2, thereby potentially inhibiting tumor growth and angiogenesis.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0594 |
| Pricing | 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, inquire |